Kristin Nielsen Varhaug

PhD Candidate

E-mailKristin.Varhaug@uib.no
Visitor Address
Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst

5009 Bergen
Postal Address
Postboks 7804

5020 Bergen

Academic article

Show author(s) (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 396-407.e6.

Show author(s) (2020). Using urine to diagnose large-scale mtDNA deletions in adult patients. Annals of clinical and translational neurology. 1318-1326.
Show author(s) (2020). Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus. The Journal of Inherited Metabolic Disease (JIMD). 800-818.
Show author(s) (2020). Polymerase gamma-relatert mitokondriesykdom. Tidsskrift for Den norske legeforening. 1-7.
Show author(s) (2020). Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. Frontiers in Neurology. 7 pages.

Show author(s) (2019). Mitochondrial complex IV is lost in neurons in the cuprizone mouse model. Mitochondrion (Amsterdam. Print). 58-62.

Show author(s) (2017). Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurology: Neuroimmunology and neuroinflammation. 1-8.
Show author(s) (2017). Multippel sklerose - en mitokondriemediert sykdom? Tidsskrift for Den norske legeforening. 274-287.

Show author(s) (2016). Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. Mitochondrion (Amsterdam. Print). 32-35.

Letter to the editor

Show author(s) (2021). Comment on “A severe linezolid-induced rhabdomyolysis and lactic acidosis in Leigh syndrome”. The Journal of Inherited Metabolic Disease (JIMD). 6-7.

Academic literature review

Show author(s) (2019). Neurofilament light chain as a biomarker in multiple sclerosis. Frontiers in Neurology. 1-6.